TY - JOUR
T1 - CD137 deficiency causes immune dysregulation with predisposition to lymphomagenesis
AU - Somekh, Ido
AU - Thian, Marini
AU - Medgyesi, David
AU - Gülez, Nesrin
AU - Magg, Thomas
AU - Duque, Alejandro Gallón
AU - Stauber, Tali
AU - Lev, Atar
AU - Genel, Ferah
AU - Unal, Ekrem
AU - Simon, Amos J.
AU - Lee, Yu Nee
AU - Kalinichenko, Artem
AU - Dmytrus, Jasmin
AU - Kraakman, Michael J.
AU - Schiby, Ginette
AU - Rohlfs, Meino
AU - Jacobson, Jeffrey M.
AU - Özer, Erdener
AU - Akcal, Ömer
AU - Conca, Raffaele
AU - Patiroglu, Türkan
AU - Karakukcu, Musa
AU - Ozcan, Alper
AU - Shahin, Tala
AU - Appella, Eliana
AU - Tatematsu, Megumi
AU - Martinez-Jaramillo, Catalina
AU - Chinn, Ivan K.
AU - Orange, Jordan S.
AU - Trujillo-Vargas, Claudia Milena
AU - Franco, José Luis
AU - Hauck, Fabian
AU - Somech, Raz
AU - Klein, Christoph
AU - Boztug, Kaan
N1 - Publisher Copyright:
© 2019 by The American Society of Hematology.
PY - 2019/10/31
Y1 - 2019/10/31
N2 - Dysregulated immune responses are essential underlying causes of a plethora of pathologies including cancer, autoimmunity, and immunodeficiency. We here investigated 4 patients from unrelated families presenting with immunodeficiency, autoimmunity, and malignancy. We identified 4 distinct homozygous mutations in TNFRSF9 encoding the tumor necrosis factor receptor superfamily member CD137/4-1BB, leading to reduced, or loss of, protein expression. Lymphocytic responses crucial for immune surveillance, including activation, proliferation, and differentiation, were impaired. Genetic reconstitution of CD137 reversed these defects. CD137 deficiency is a novel inborn error of human immunity characterized by lymphocytic defects with early-onset Epstein-Barr virus (EBV)- associated lymphoma.Our findings elucidate a functional role and relevance of CD137 in human immune homeostasis and antitumor responses.
AB - Dysregulated immune responses are essential underlying causes of a plethora of pathologies including cancer, autoimmunity, and immunodeficiency. We here investigated 4 patients from unrelated families presenting with immunodeficiency, autoimmunity, and malignancy. We identified 4 distinct homozygous mutations in TNFRSF9 encoding the tumor necrosis factor receptor superfamily member CD137/4-1BB, leading to reduced, or loss of, protein expression. Lymphocytic responses crucial for immune surveillance, including activation, proliferation, and differentiation, were impaired. Genetic reconstitution of CD137 reversed these defects. CD137 deficiency is a novel inborn error of human immunity characterized by lymphocytic defects with early-onset Epstein-Barr virus (EBV)- associated lymphoma.Our findings elucidate a functional role and relevance of CD137 in human immune homeostasis and antitumor responses.
UR - http://www.scopus.com/inward/record.url?scp=85074507331&partnerID=8YFLogxK
U2 - 10.1182/blood.2019000644
DO - 10.1182/blood.2019000644
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 31501153
AN - SCOPUS:85074507331
SN - 0006-4971
VL - 134
SP - 1510
EP - 1516
JO - Blood
JF - Blood
IS - 18
ER -